Science and Research

MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically

Evasion of programmed cell death represents a critical form of oncogene addiction in cancer cells. Understanding the molecular mechanisms underpinning cancer cell survival despite the oncogenic stress could provide a molecular basis for potential therapeutic interventions. Here we explore the role of pro-survival genes in cancer cell integrity during clonal evolution in non-small cell lung cancer (NSCLC). We identify gains of MCL-1 at high frequency in multiple independent NSCLC cohorts, occurring both clonally and subclonally. Clonal loss of functional TP53 is significantly associated with subclonal gains of MCL-1. In mice, tumour progression is delayed upon pharmacologic or genetic inhibition of MCL-1. These findings reveal that MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.

  • Munkhbaatar, E.
  • Dietzen, M.
  • Agrawal, D.
  • Anton, M.
  • Jesinghaus, M.
  • Boxberg, M.
  • Pfarr, N.
  • Bidola, P.
  • Uhrig, S.
  • Höckendorf, U.
  • Meinhardt, A. L.
  • Wahida, A.
  • Heid, I.
  • Braren, R.
  • Mishra, R.
  • Warth, A.
  • Muley, T.
  • Poh, P. S. P.
  • Wang, X.
  • Fröhling, S.
  • Steiger, K.
  • Slotta-Huspenina, J.
  • van Griensven, M.
  • Pfeiffer, F.
  • Lange, S.
  • Rad, R.
  • Spella, M.
  • Stathopoulos, G. T.
  • Ruland, J.
  • Bassermann, F.
  • Weichert, W.
  • Strasser, A.
  • Branca, C.
  • Heikenwalder, M.
  • Swanton, C.
  • McGranahan, N.
  • Jost, P. J.

Keywords

  • Animals
  • Antineoplastic Agents/*pharmacology/therapeutic use
  • Apoptosis/drug effects/genetics
  • Carcinoma, Non-Small-Cell Lung/diagnostic imaging/drug therapy/*genetics/pathology
  • Cell Line, Tumor
  • Cell Survival/drug effects/genetics
  • Clonal Evolution
  • DNA Copy Number Variations
  • Datasets as Topic
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • Lung/diagnostic imaging/pathology
  • Lung Neoplasms/diagnostic imaging/drug therapy/*genetics/pathology
  • Mice
  • Mice, Transgenic
  • Mutation
  • Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors/*genetics
  • Primary Cell Culture
  • Prospective Studies
  • Proto-Oncogene Proteins p21(ras)/genetics
  • Pyrimidines/pharmacology/therapeutic use
  • RNA-Seq
  • Retrospective Studies
  • Spheroids, Cellular
  • Thiophenes/pharmacology/therapeutic use
  • Tumor Burden/drug effects/genetics
  • Tumor Suppressor Protein p53/genetics
  • X-Ray Microtomography
Publication details
DOI: 10.1038/s41467-020-18372-1
Journal: Nat Commun
Pages: 4527 
Number: 1
Work Type: Original
Location: CPC-M, TLRC
Disease Area: LC
Partner / Member: DKGZ, HMGU, Thorax
Access-Number: 32913197

DZL Engagements

chevron-down